Akums Drugs & Pharmaceuticals Ltd — Quarterly Results & Earnings

₹466.10

-3.81%

Profit Growth YoY-34.83%Latest quarter

Sales Growth YoY-1.51%Latest quarter

Sales CAGR 5Y11.27%5 year compound

Profit CAGR 5Y48.93%5 year compound

📋

Quarterly Performance

YoY Profit Growth-34.83%

🔴 Significant decline

YoY Sales Growth-1.51%

⚠️ Mild contraction

OPM 5Y Average

Operating profit margin

5.62%

EPS Growth 5Y

-42.93%

Interest Coverage

Higher = safer debt servicing

6.61

ROE

17.19%

ROCE

16.20%

💡

Growth Analysis

Akums Drugs & Pharmaceuticals Ltd reported YoY profit growth of -34.83% and revenue growth of -1.51% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 11.27% and profits at 48.93% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Akums Drugs & Pharmaceuticals Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.